Author

Kotaro Oiwa

Nagoya UniversityORCID 0000-0001-7797-6384Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Assay:metabolomics· 1

Frequent Co-Authors

Brian Kirk· 1 shared Chynna Bowman· 1 shared Daniela BoassaiD· 1 shared Elise MacDonaldiD· 1 shared Fred H. GageiD· 1 shared George J. MurphyiD· 1 shared Jeffrey R. JonesiD· 1 shared Jérôme MertensiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Brian Kirk

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NeurosciencebioRxivPreprintOct 1, 2026

An age-preserving neuronal iSpheroid platform for modeling human aging and Alzheimer disease

Samhan Alsolami, Meiyan Wang, Thaís S. Sabedot…·Fred H. Gage

This paper introduces an age-preserving neuronal iSpheroid platform that models human aging and Alzheimer's disease, revealing disease-associated metabolic changes and potential therapeutic targets.

DOI 10.64898/2026.09.30.755853

humannon-human primate

𝕏 PostBluesky

NeurosciencebioRxivPreprintApr 29, 2025

TBK1 eliminates aggregation-prone monomeric TDP-43 through the IFNβ-immunoproteasome pathway

Shohei Sakai, Kotaro Oiwa, Yohei Iguchi…·Koji Yamanaka

This study identifies the TBK1-IFNβ-immunoproteasome pathway as a mechanism by which TBK1 reduces TDP-43 aggregation in ALS and FTD.

DOI 10.1101/2025.04.29.650889

humanmouse

𝕏 PostBluesky